Number | Percentage | |||
---|---|---|---|---|
Patients | 285 | |||
Disease status at transplant | Complete response | Total CR | 178 | 62 |
CR1 | 93 | |||
CR ≥ 2 | 85 | |||
Partial response | Total PR | 76 | 27 | |
PR1 | 45 | |||
PR ≥ 2 | 31 | |||
Progressive disease | 31 | 11 | ||
Time from diagnosis to transplant | < 12 months | 149 | 52 | |
Conditioning regimen | RIC | 174 | 62 | |
MAC | Total MAC | 107 | 38 | |
TBI-based MAC | 67 | |||
Missing data | 4 | |||
Graft source | PBSC | 203 | 71 | |
Bone marrow | 49 | 17 | ||
CB | 33 | 12 | ||
Sex of donor/recipient | F/M | 74 | 27 | |
CMV serostatus | Neg/neg | 92 | 32 | |
HLA matching | Sibling identical | 128 | 45 | |
Matched unrelated donor (10/10) | 104 | 36 | ||
Mismatched unrelated donor | 13 | 5 | ||
Cord blood | 33 | 12 | ||
Haploidentical | 7 | 2 | ||
T depletion | In vivo T depletion (ATG) | 142 | 50 | |
Ex vivo T depletion | 4 | 1 |